Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Pharmaceutical Group (Benxi) North Pharmaceutical is a major industrial subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., serving as the group's primary manufacturing and R&D hub in Northern China. Established in the Benxi High-tech Zone (China Medicine Capital), the company specializes in the production of chemical active pharmaceutical ingredients (APIs) and oral solid dosage forms. Its operations are centered on high-volume therapeutic areas including anti-infectives, cardiovascular health, and metabolic disorders. The company plays a critical role in the parent organization's vertical integration strategy, ensuring high-quality supply chains for both domestic and international markets through its GMP-certified facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Pharmaceutical Group (Benxi) North Pharmaceutical.